Lab or animal research
PE-22-28 primary study · PMID 28955242
Cell electrophysiology assays and mouse behavioral models.
Reported findings. The peptide inhibited TREK-1 in laboratory assays and affected mouse behavioral endpoints.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. Mouse behavioral tests do not establish an antidepressant treatment, human benefit or long-term safety.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.